KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
7.50
+0.30 (4.17%)
Aug 12, 2025, 4:00 PM - Market closed
Oncternal Therapeutics Market Cap
KALA BIO has a market cap or net worth of $48.01 million as of August 12, 2025. Its market cap has increased by 135.32% in one year.
Market Cap
48.01M
Enterprise Value
44.45M
1-Year Change
135.32%
Ranking
Category
Stock Price
$7.50
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $48.01M, a decrease of -88.85%. That is a compound annual growth rate of -23.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 50.60M | 58.13% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 583.99B |
| Johnson & Johnson | 417.29B |
| AbbVie | 348.35B |
| UnitedHealth Group | 230.66B |
| AstraZeneca | 227.85B |
| Abbott Laboratories | 227.60B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |